(1)
ANALYSIS OF PROBLEMS SPECIFIC TO THE FIELD OF DRUG DEVELOPMENT BY INTERNATIONAL AND RUSSIAN MANUFACTURING COMPANIES. Rev. incl. 2020, 71-83.